PRIMARY IMMUNODEFICIENCY
Clinical trials for PRIMARY IMMUNODEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new PRIMARY IMMUNODEFICIENCY trials appear
Sign up with your email to follow new studies for PRIMARY IMMUNODEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody shot tested for immune-deficient patients
Disease control OngoingThis study tests a medicine called IgPro20, given as a shot under the skin, in 8 adults with primary immunodeficiency (PID) who have never received antibody therapy before. The goal is to see how the drug works in the body and whether it is safe. Participants must be 18 or older …
Matched conditions: PRIMARY IMMUNODEFICIENCY
Phase: PHASE4 • Sponsor: CSL Behring • Aim: Disease control
Last updated May 17, 2026 08:03 UTC
-
Skin biopsies could pave way for future gene therapies
Knowledge-focused ENROLLING_BY_INVITATIONThis study takes small skin samples from people with immune system problems and healthy volunteers. The goal is to grow skin cells in the lab to study how the immune system works. These cells may one day help create personalized gene therapies for immune diseases. Participants mu…
Matched conditions: PRIMARY IMMUNODEFICIENCY
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC